Prostatic Neoplasms: Clinical Trials

2 trials for Prostatic Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 enrolling by invitation. 2 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Enrolling by invitation 2
Phase 11Enrolling by invitation 1
Phase 31Enrolling by invitation 1

Follow Prostatic Neoplasms: new trials by email Literature Review of Prostatic Neoplasms trials Research Report on Prostatic Neoplasms

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol
ZEN003694, Enzalutamide - mCRPC
Phase 1 / Phase 2Enrolling by invitationZenith Epigenetics402019-11-122026-05-08
Prostate Cancer Patient Management With 18F-DCFPyL PET/CT
18F-DCFPyL PET/CT - Prostate Cancer
Phase 2 / Phase 3Enrolling by invitationSir Mortimer B. Davis - Jewish General Hospital15002018-06-222023-11-27

Broader conditions

Genital Diseases (2)  ·  Genital Diseases, Male (2)  ·  Genital Neoplasms, Male (2)  ·  Male Urogenital Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Prostatic Diseases (2)  ·  Urogenital Diseases (2)  ·  Urogenital Neoplasms (2)

Interventions

enzalutamide (1)

Sponsors

Sir Mortimer B. Davis - Jewish General Hospital (1)  ·  Zenith Epigenetics (1)

Countries

Canada (1)  ·  United States (1)